FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephen Riggs

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Jeffrey C La Rochelle; Brian Shuch; Stephen B Riggs; Li-Jung Liang; Ardavan Saadat; Fairooz Kabbinavar; Allan J Pantuck; Arie Belldegrun
Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
Tobias Klatte; David B Seligson; Jeffrey C La Rochelle; Brian Shuch; Jonathan W Said; Stephen B Riggs; Nazy Zomorodian; Fairooz Kabbinavar; Allan J Pantuck; Arie S Belldegrun
Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Arie S Belldegrun; Tobias Klatte; Brian Shuch; Jeffrey C La Rochelle; David C Miller; Jonathan W Said; Stephen B Riggs; Nazy Zomorodian; Fairooz Kabbinavar; Jean B deKernion; Allan J Pantuck
Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephen Riggs (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Jeffrey C La Rochelle; Brian Shuch; Stephen B Riggs; Li-Jung Liang; Ardavan Saadat; Fairooz Kabbinavar; Allan J Pantuck; Arie Belldegrun
Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
The Journal of urology 2009;181(5):2037-42; discussion 2043.
2009: Tobias Klatte; David B Seligson; Jeffrey C La Rochelle; Brian Shuch; Jonathan W Said; Stephen B Riggs; Nazy Zomorodian; Fairooz Kabbinavar; Allan J Pantuck; Arie S Belldegrun
Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(3):894-900.
2008: Arie S Belldegrun; Tobias Klatte; Brian Shuch; Jeffrey C La Rochelle; David C Miller; Jonathan W Said; Stephen B Riggs; Nazy Zomorodian; Fairooz Kabbinavar; Jean B deKernion; Allan J Pantuck
Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.
Cancer 2008;113(9):2457-63.
2008: Brian Shuch; Jeffrey C La Rochelle; Tobias Klatte; Stephen B Riggs; Weiqing Liu; Fairooz Kabbinavar; Allan J Pantuck; Arie S Belldegrun
Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival.
Cancer 2008;113(7):1641-8.
2008: Brian Shuch; Jeffrey C La Rochelle; Jon Wu; Tobias Klatte; Stephen B Riggs; Fairooz Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.
Cancer 2008;113(6):1324-31.
2008: Stephen B Riggs; Jeffrey C La Rochelle; Arie S Belldegrun
Partial nephrectomy: a contemporary review regarding outcomes and different techniques.
Cancer journal (Sudbury, Mass.) 2008;14(5):302-7.
2008: Brian Shuch; Stephen B Riggs; Jeffrey C La Rochelle; Fairooz Kabbinavar; Raffi Avakian; Allan J Pantuck; Jean-Jacques Patard; Arie S Belldegrun
Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm.
BJU international 2008;102(6):692-6.
2008: Tobias Klatte; Jean-Jacques Patard; Michela de Martino; Karim Bensalah; Gregory Verhoest; Alexandre de la Taille; Clément-Claude Abbou; Ernst Peter Allhoff; Giuseppe Carrieri; Stephen B Riggs; Fairooz Kabbinavar; Arie S Belldegrun; Allan J Pantuck
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
The Journal of urology 2008;179(5):1719-26.
2008: Alberto Breda; John S Lam; Stephen B Riggs; John T Leppert; Dorina Gui; Jonathan W Said; Peter Schulam; Arie S Belldegrun
In vivo efficacy of laparoscopic assisted percutaneous renal cryotherapy: evidence based guidelines for the practicing urologist.
The Journal of urology 2008;179(1):333-7.
2008: Tobias Klatte; David Seligson; John T Leppert; Stephen B Riggs; Hong Yu; Nazy Zomorodian; Fairooz Kabbinavar; Robert M Strieter; Arie S Belldegrun; Allan J Pantuck
The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma.
The Journal of urology 2008;179(1):61-6.
2007: Tobias Klatte; David Seligson; Stephen B Riggs; John T Leppert; Maria K Berkman; Mark D Kleid; Hong Yu; Fairooz Kabbinavar; Allan J Pantuck; Arie S Belldegrun
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(24):7388-93.
2007: Robert E Reiter; Stephen B Riggs
What factors affect the PSA relapse-free survival times in patients treated with permanent seed brachytherapy?
Nature clinical practice. Urology 2007;4(12):650-1.
2007: Stephen B Riggs; Tobias Klatte; Arie S Belldegrun
Update on partial nephrectomy and novel techniques.
Urologic oncology 2007;25(6):520-2.
2007: Tobias Klatte; Allan J Pantuck; Stephen B Riggs; Mark D Kleid; Brian Shuch; Nazy Zomorodian; Fairooz Kabbinavar; Arie S Belldegrun
Prognostic factors for renal cell carcinoma with tumor thrombus extension.
The Journal of urology 2007;178(4 Pt 1):1189-95; discussion 1195.